116 related articles for article (PubMed ID: 36395875)
1. A Randomized Trial of Clopidogrel vs Ticagrelor After Off-Pump Coronary Bypass.
Kim HH; Yoo KJ; Youn YN
Ann Thorac Surg; 2023 May; 115(5):1127-1134. PubMed ID: 36395875
[TBL] [Abstract][Full Text] [Related]
2. Posttreatment platelet reactivity on clopidogrel is associated with the risk of adverse events after off-pump coronary artery bypass.
Youn YN; Yi G; Lee S; Joo HC; Yoo KJ
Am Heart J; 2014 Jun; 167(6):818-25. PubMed ID: 24890530
[TBL] [Abstract][Full Text] [Related]
3. Antiplatelet effects of ticagrelor versus clopidogrel after coronary artery bypass graft surgery: A single-center randomized controlled trial.
Xu F; Feng W; Zhou Z; Zhang Y; Diao X; Hu S; Zheng Z
J Thorac Cardiovasc Surg; 2019 Aug; 158(2):430-437.e4. PubMed ID: 30501950
[TBL] [Abstract][Full Text] [Related]
4. Postoperative clopidogrel improves mid-term outcome after off-pump coronary artery bypass graft surgery: a prospective study.
Gurbuz AT; Zia AA; Vuran AC; Cui H; Aytac A
Eur J Cardiothorac Surg; 2006 Feb; 29(2):190-5. PubMed ID: 16388957
[TBL] [Abstract][Full Text] [Related]
5. Aspirin plus clopidogrel for optimal platelet inhibition following off-pump coronary artery bypass surgery: results from the CRYSSA (prevention of Coronary arteRY bypaSS occlusion After off-pump procedures) randomised study.
Mannacio VA; Di Tommaso L; Antignan A; De Amicis V; Vosa C
Heart; 2012 Dec; 98(23):1710-5. PubMed ID: 22942294
[TBL] [Abstract][Full Text] [Related]
6. Comparison of dual antiplatelet therapies after coronary endarterectomy combined with coronary artery bypass grafting: a cohort study.
Yan H; Tiemuerniyazi X; Song Y; Xu F; Feng W
J Cardiothorac Surg; 2020 Jun; 15(1):155. PubMed ID: 32600365
[TBL] [Abstract][Full Text] [Related]
7. Ticagrelor versus clopidogrel in patients with symptomatic peripheral artery disease and prior coronary artery disease: Insights from the EUCLID trial.
Berger JS; Abramson BL; Lopes RD; Heizer G; Rockhold FW; Baumgartner I; Fowkes FGR; Held P; Katona BG; Norgren L; Jones WS; Millegård M; Blomster J; Reist C; Hiatt WR; Patel MR; Mahaffey KW
Vasc Med; 2018 Dec; 23(6):523-530. PubMed ID: 29992857
[TBL] [Abstract][Full Text] [Related]
8. Clinical efficacy of clopidogrel and ticagrelor in patients undergoing off-pump coronary artery bypass grafting: a retrospective cohort study.
Wang Z; Ma R; Li X; Li X; Xu Q; Yao Y; Wang C; Lv Q
Int J Surg; 2024 Jun; 110(6):3450-3460. PubMed ID: 38445500
[TBL] [Abstract][Full Text] [Related]
9. A randomized, parallel group, double-blind study of ticagrelor compared with aspirin for prevention of vascular events in patients undergoing coronary artery bypass graft operation: Rationale and design of the Ticagrelor in CABG (TiCAB) trial: An Investigator-Initiated trial.
de Waha A; Sandner S; von Scheidt M; Boening A; Koch-Buettner K; Hammel D; Hambrecht R; Danner BC; Schöndube FA; Goerlach G; Fischlein T; Schmoeckel M; Oberhoffer M; Schulz R; Walther T; Ziegelhöffer T; Knosalla C; Schönrath F; Beyersdorf F; Siepe M; Attmann T; Misfeld M; Mohr FW; Sievers HH; Joost A; Putman LM; Laufer G; Hamm C; Zeymer U; Kastrati A; Radke PW; Lange R; Cremer J; Schunkert H
Am Heart J; 2016 Sep; 179():69-76. PubMed ID: 27595681
[TBL] [Abstract][Full Text] [Related]
10. Bleeding complications after dual antiplatelet therapy with ticagrelor versus dual antiplatelet therapy with clopidogrel-a propensity-matched comparative study of two antiplatelet regimes in off-pump coronary artery bypass grafting.
Varma PK; Ahmed H; Krishna N; Jose R; Gopal K; Mathew OP; Jayant A
Indian J Thorac Cardiovasc Surg; 2021 Jan; 37(1):27-37. PubMed ID: 33442205
[TBL] [Abstract][Full Text] [Related]
11. Assessment of Ticagrelor Versus Clopidogrel Treatment in Patients With ST-elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
Tang X; Li R; Jing Q; Wang Q; Liu P; Zhang P; Liu Y
J Cardiovasc Pharmacol; 2016 Aug; 68(2):115-20. PubMed ID: 27010809
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and Safety of Ticagrelor in Comparison to Clopidogrel in Elderly Patients With ST-Segment-Elevation Myocardial Infarctions.
Schmucker J; Fach A; Mata Marin LA; Retzlaff T; Osteresch R; Kollhorst B; Hambrecht R; Pohlabeln H; Wienbergen H
J Am Heart Assoc; 2019 Sep; 8(18):e012530. PubMed ID: 31538856
[TBL] [Abstract][Full Text] [Related]
13. Randomized trial of ticagrelor vs. aspirin in patients after coronary artery bypass grafting: the TiCAB trial.
Schunkert H; Boening A; von Scheidt M; Lanig C; Gusmini F; de Waha A; Kuna C; Fach A; Grothusen C; Oberhoffer M; Knosalla C; Walther T; Danner BC; Misfeld M; Zeymer U; Wimmer-Greinecker G; Siepe M; Grubitzsch H; Joost A; Schaefer A; Conradi L; Cremer J; Hamm C; Lange R; Radke PW; Schulz R; Laufer G; Grieshaber P; Pader P; Attmann T; Schmoeckel M; Meyer A; Ziegelhöffer T; Hambrecht R; Kastrati A; Sandner SE
Eur Heart J; 2019 Aug; 40(29):2432-2440. PubMed ID: 31145798
[TBL] [Abstract][Full Text] [Related]
14. Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial.
Ohman EM; Roe MT; Steg PG; James SK; Povsic TJ; White J; Rockhold F; Plotnikov A; Mundl H; Strony J; Sun X; Husted S; Tendera M; Montalescot G; Bahit MC; Ardissino D; Bueno H; Claeys MJ; Nicolau JC; Cornel JH; Goto S; Kiss RG; Güray Ü; Park DW; Bode C; Welsh RC; Gibson CM
Lancet; 2017 May; 389(10081):1799-1808. PubMed ID: 28325638
[TBL] [Abstract][Full Text] [Related]
15. Ticagrelor or Aspirin After Coronary Artery Bypass in Patients With Chronic Kidney Disease.
Sandner SE; Schunkert H; Kastrati A; Milojevic M; Böning A; Zimpfer D; Zellmer S; Wiedemann D; Laufer G; von Scheidt M;
Ann Thorac Surg; 2022 Feb; 113(2):554-562. PubMed ID: 33819474
[TBL] [Abstract][Full Text] [Related]
16. Clopidogrel versus ticagrelor or prasugrel in patients aged 70 years or older with non-ST-elevation acute coronary syndrome (POPular AGE): the randomised, open-label, non-inferiority trial.
Gimbel M; Qaderdan K; Willemsen L; Hermanides R; Bergmeijer T; de Vrey E; Heestermans T; Tjon Joe Gin M; Waalewijn R; Hofma S; den Hartog F; Jukema W; von Birgelen C; Voskuil M; Kelder J; Deneer V; Ten Berg J
Lancet; 2020 Apr; 395(10233):1374-1381. PubMed ID: 32334703
[TBL] [Abstract][Full Text] [Related]
17. Ticagrelor in Patients with Stable Coronary Disease and Diabetes.
Steg PG; Bhatt DL; Simon T; Fox K; Mehta SR; Harrington RA; Held C; Andersson M; Himmelmann A; Ridderstråle W; Leonsson-Zachrisson M; Liu Y; Opolski G; Zateyshchikov D; Ge J; Nicolau JC; Corbalán R; Cornel JH; Widimský P; Leiter LA;
N Engl J Med; 2019 Oct; 381(14):1309-1320. PubMed ID: 31475798
[TBL] [Abstract][Full Text] [Related]
18. Ticagrelor versus clopidogrel in acute myocardial infarction patients with multivessel disease; From Korea Acute Myocardial Infarction Registry-National Institute of Health.
Ahn JH; Ahn Y; Jeong MH; Kim JH; Hong YJ; Sim DS; Kim MC; Hwang JY; Yoon JH; Seong IW; Hur SH; Oh SK;
J Cardiol; 2020 May; 75(5):478-484. PubMed ID: 31859138
[TBL] [Abstract][Full Text] [Related]
19. [Effect of aspirin plus clopidogrel therapy on aspirin resistance after off-pump coronary artery bypass surgery].
Wang XZ; Gong XX; Zhu TT; Li CJ; Yang ZJ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2013 Oct; 35(5):495-502. PubMed ID: 24183037
[TBL] [Abstract][Full Text] [Related]
20. Unguided de-escalation from ticagrelor to clopidogrel in stabilised patients with acute myocardial infarction undergoing percutaneous coronary intervention (TALOS-AMI): an investigator-initiated, open-label, multicentre, non-inferiority, randomised trial.
Kim CJ; Park MW; Kim MC; Choo EH; Hwang BH; Lee KY; Choi YS; Kim HY; Yoo KD; Jeon DS; Shin ES; Jeong YH; Seung KB; Jeong MH; Yim HW; Ahn Y; Chang K;
Lancet; 2021 Oct; 398(10308):1305-1316. PubMed ID: 34627490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]